Most Recent Articles by Leah Lawrence
Patients diagnosed with MIBC are at a significant risk for death — which has not greatly improved in the last few decades.
Regular exercise can help patients with cancer deal with issues related to weight gain during treatment.
While APHINITY showed a small improvement with adjuvant pertuzumab, it is unclear whether the benefits are worth the cost, time, and toxicity associated with the drug.
The combination may be an attractive option for some, but further research is needed to target the therapy effectively to particular patients.
Patients who indicated a decreased level of physical activity at 3 years after diagnosis had a worse overall and lymphoma-specific survival compared with those who did not report a change.
More Articles by Leah Lawrence
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Hyperthermia Plus Chemotherapy Improves Survival in Soft Tissue Sarcoma
- Survey May Help To Identify Patients With Cancer at Risk of HBV Reactivation
- Fish Consumption and Cancer
- Socioeconomic Status May Preclude Elderly Patients From Receiving Pancreatic Cancer Treatment
- Receptor Agonists With Palonosetron May Reduce Needed Dexamethasone Duration